Objectives and Design of BLEEDS: A Cohort Study to Identify New Risk Factors and Predictors for Major Bleeding during Treatment with Vitamin K Antagonists

por van Rein, Nienke, Lijfering, Willem M., Bos, Mettine H. A., Herruer, Martien H., Vermaas, Helga W., van der Meer, Felix J. M., Reitsma, Pieter H.
Publicado 2016

Self‐reported therapy adherence and predictors for nonadherence in patients who switched from vitamin K antagonists to direct oral anticoagulants

por Toorop, Myrthe M. A., van Rein, Nienke, Nierman, Melchior C., Vermaas, Helga W., Huisman, Menno V., van der Meer, Felix J. M., Cannegieter, Suzanne C., Lijfering, Willem M.
Publicado 2020

Switching from vitamin K antagonists to direct oral anticoagulants: Treatment satisfaction and patient concerns

por Toorop, Myrthe M. A., van Rein, Nienke, Nierman, Melchior C., Vermaas, Helga W., Huisman, Menno V., van der Meer, Felix J. M., Cannegieter, Suzanne C., Lijfering, Willem M.
Publicado 2020

Inter‐ and intra‐individual concentrations of direct oral anticoagulants: The KIDOAC study

por Toorop, Myrthe M. A., van Rein, Nienke, Nierman, Melchior C., Vermaas, Helga W., Huisman, Menno V., van der Meer, Felix J. M., Cannegieter, Suzanne C., Lijfering, Willem M.
Publicado 2021